What does this video actually claim?
Miila shares her experience with GLP-1 medications, emphasizing psychological and emotional benefits beyond weight loss. She says the treatment helped her "recognize herself again" and "feel like she got herself back."
This represents a common theme in GLP-1 testimonials where users describe profound changes in self-perception and confidence. The video focuses entirely on personal transformation rather than making specific medical claims about the medication's effects.
While her message is inspirational, it raises questions about whether these psychological benefits stem directly from the medication or from the weight loss it enables.
Do GLP-1 medications affect mental health directly?
The science here is mixed and still developing. GLP-1 receptors exist in brain regions that regulate mood and behavior, suggesting potential direct effects.
The STEP 1 trial (Wilding et al., NEJM, 2021) found improvements in quality of life measures with semaglutide 2.4mg, but these were measured alongside 14.9% weight loss. A smaller study by Blomain et al. (Diabetes Care, 2018) found that liraglutide reduced binge eating episodes independently of weight loss.
However, the SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) noted mood-related side effects in some participants taking tirzepatide. The relationship between GLP-1 medications and mental health isn't straightforward.
How much comes from weight loss versus the drug itself?
This is where things get complicated. Most studies can't separate the medication's direct effects from the psychological benefits of losing weight.
The Look AHEAD trial (Wing et al., NEJM, 2013) showed that any significant weight loss, regardless of method, improves self-esteem and body image. People who lose 10-15% of their body weight through diet and exercise report similar confidence boosts to what Miila describes.
What makes GLP-1s different is how they change eating behavior. Users report reduced food noise and fewer cravings, which might contribute to feeling "like themselves again" beyond just the physical changes.
What's missing from this narrative?
Miila's experience sounds genuine, but her account skips over some important realities. Not everyone experiences these transformative psychological effects.
The STEP trials reported that 5-10% of participants discontinued semaglutide due to side effects, primarily nausea and gastrointestinal issues. Some people feel worse on these medications, not better.
Weight regain is also common when stopping treatment. The STEP 1 extension study showed participants regained about two-thirds of lost weight within a year of stopping semaglutide. This raises questions about long-term psychological benefits if they're tied to maintaining weight loss.
What should you actually know?
Miila's experience reflects what many people report, but individual results vary dramatically. The psychological benefits she describes aren't guaranteed effects of GLP-1 medications.
If you're considering these medications, focus on the concrete clinical data: semaglutide 2.4mg produces average weight loss of 12-15% in clinical trials. Some people experience improved mood and confidence, while others struggle with side effects.
The "getting yourself back" feeling might come from the weight loss, reduced food preoccupation, or direct brain effects. Science hasn't sorted this out yet, and it probably varies between individuals.